Michael Atkin Email and Phone Number
Michael Atkin work email
- Valid
- Valid
- Valid
- Valid
- Valid
Michael Atkin personal email
- Valid
Results driven life sciences leader, with experience building companies, advancing drugs and partnering technologies and companies. Successful biotechnology CEO with pharmaceutical leadership experience. Record of success in directing drug candidates towards filling unmet medical needs and bridging from discovery through preclinical development to successful clinical trials. Facility for building board consensus around company strategy and milestones, plus hands-on implementation. Proven track record of building strong participative management teams, successful collaborations and fund raising. Experience grooming companies for exit, based on biotech and pharma market dynamics. Strong inter-personal, analytical and negotiation skills. Interested in helping companies to grow, excellent life sciences network.Specialties: Fundraising, building management teams, working with key opinion leaders, understanding unmet medical needs, experience as board member and Executive Chair, business development, developing business strategies, winning consensus
Affinité Instruments
View-
CeoSynergy Therapeutics Inc. Mar 2023 - PresentNew approaches and compounds for an old oncology target: p53.
-
DirectorSyzent Partners Llc Jul 2022 - Present
-
Board MemberAffinité Instruments Jan 2016 - PresentMontreal, Quebec, CaAffinité is a spin-off from the Université de Montréal chemistry department, working on robust label-free detection and imaging methods that put research-level instruments on the benchtop; first product is SPR, pipeline is exciting, with future bridges towards precision diagnostics.
-
Industry MentorRutgers University Jun 2023 - Dec 2023New Brunswick, Nj, UsMentoring a Rutgers NSF I-Corps national team after working with them and 4 other university technologies in a regional program early in 2023. We need to interview 100+ customers to learn if there is a fit with unmet medical needs in ADHD & binge-eating disorders for an adjuvant that mitigates stimulant challenges such as wake-promoting properties and abuse liability. If you have 15 minutes to share your thoughts, please get in touch. Thank you. -
Industry MentorPrinceton University Mar 2023 - Dec 2023Princeton, Nj, UsSTART Entrepreneur Mentor for a Princeton University technology with significant potential. Maksim Mezhericher, MSc, PhD and Prof. Howard Stone have created an innovative liquid atomization and drying technology that works at room temperature. This technology holds promise to enable room-temperature storage of certain classes of biologic. More info. on this future spin-out at: https://inaediscom.wordpress.com/ -
General ManagerNmx Research And Solutions Inc Dec 2021 - Jul 2022Laval, Québec, CaNMX uses biophysics tools and proprietary analysis knowhow to speed SAR and lead drug identification for its clients and its own research. -
Chairman Of The BoardOrtho Rti Jun 2020 - Jul 2022Kirkland, Québec, CaI look forward to working closely with Claude LeDuc, President and CEO of Ortho Regenerative Technologies Inc. and the Board as the company advances to its US pilot clinical trial, combining its proprietary chitosan formulation with Platelet-Rich Plasma (PRP) in treatment of rotator cuff tears versus standard of care. Ortho RTI’s proprietary technology platform possesses all the right elements to improve surgery outcomes, satisfy significant unmet medical needs and make Ortho RTI a leader in the soft tissue repair market. I look forward to benefiting from the continued counsel on the Board of Ortho's former Chairman, Steve Saviuk, who played a critical leadership role advancing Ortho RTI to its exciting position today. -
DirectorSyzent Partners Ltd. Sep 2011 - Jul 2022Consulting in life sciences to advance early-stage technologies to critical inflection points, securing financing, collaborations and preclinical plus clinical milestones. Proven strategy development/ implementation skills. Significant biotech. business development experience includes mergers, acquisitions, licenses, sale of products and research collaborations.
-
President & CeoGladius Pharmaceuticals Inc. Jun 2015 - Apr 2019Working closely with Domenic De Luca, CFO and with Scientific Founder, Larry Sutton, MD, PhD. The company focus is discovery and development of dual function, beta-lactam antibiotics for the treatment of multi-drug-resistant, bacterial infections. On June 22nd we announced a CDN$ 4.1 million financing led by Lumira Capital, with the participation of Fonds de Solidarité FTQ and SR One which participated with funds from the GlaxoSmithKline (GSK) Canada Life Sciences Innovation Fund.
-
ChairmanSopharmia Inc. 2012 - 2013
-
Managing DirectorSyzent Partners Jan 2010 - Aug 2011Partnerships, financings and development milestones don’t happen by accident. You need to line up all the elements to close the deal. The astronomical term describing three planetary bodies in alignment is syzygy, hence SYZent Partners. Current clients include McGill University with its novel hypnotic drug discovery and development program, for which Michael successfully raised $0.9 million in financing. Michael is also working with life science companies to provide insight on licensing valuation and deal terms, and is discussing a new university assignment. .
-
PrincipalMichael Atkin Oct 2008 - May 2010I'm building my own life science consulting firm, helping companes and investors with strategic decisions, transitions and BD and fund raising mandates.
-
CeoUlysses Pharma 2006 - 2008
-
Founder & CeoAegera Therapeutics Inc. 2000 - 2005Ca -
Director, New Products, Neuroscience Global MarketingBristol-Myers Squibb 1995 - 1999Lawrence Township, Nj, Us -
Vp, Business DevelopmentLederle International 1993 - 1995
-
Strategic PlannerEmhart Corporation 1981 - 1985
Michael Atkin Skills
Michael Atkin Education Details
-
Columbia Business SchoolFinance -
University Of KentBa (Hons.)
Frequently Asked Questions about Michael Atkin
What company does Michael Atkin work for?
Michael Atkin works for Affinité Instruments
What is Michael Atkin's role at the current company?
Michael Atkin's current role is Advancing oncology start-up with very promising target product profile addressing umet needs.
What is Michael Atkin's email address?
Michael Atkin's email address is ma****@****bia.edu
What schools did Michael Atkin attend?
Michael Atkin attended Columbia Business School, University Of Kent.
What are some of Michael Atkin's interests?
Michael Atkin has interest in Application Of New Scientific Insights, Hiking, Management Of Innovation, Taking Film Photos On My Hasselblad.
What skills is Michael Atkin known for?
Michael Atkin has skills like Biotechnology, Business Development, Business Strategy, Management, Strategy, Clinical Development, Pharmaceutical Industry, Drug Discovery, Lifesciences, Life Sciences, Fundraising, Technology Transfer.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial